PF-03758309
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PF-03758309, covering 2013-03-06 to 2013-03-06. Get the full timeline:
Most recent: Clinical Trial Update: This Is The First Study Using Escalating Doses Of PF-03758309, An Oral Compound, In Patients With Advanced Solid Tumors [Phase 1]